Drug Free Solution, Inc. (OTCPK:DSOL) announced that it has entered into a equity purchase agreement for a private placement of equity line of credit for gross proceeds of $3,000,000 with new investor Premier Venture Partners, LLC on July 14, 2014. Pursuant to the agreement, the investor shall purchase the shares over a period of 36 months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -.--% | -.--% | -.--% |
2021 | Drug Free Solution, Inc. Announces Jessica Bass as CEO | CI |
2021 | Drug Free Solution, Inc. Announces Genie O'Malley as Chairwoman of the Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 88.89K | |
+24.47% | 88.24B | |
-23.13% | 76.2B | |
+0.49% | 26.63B | |
+5.59% | 18.14B | |
-12.89% | 16.69B | |
+3.49% | 15.85B | |
+76.87% | 13.61B | |
+79.38% | 13.24B | |
+38.44% | 12.72B |
- Stock Market
- Equities
- DSOL Stock
- News Drug Free Solution, Inc.
- Drug Free Solution, Inc. announced that it expects to receive $3 million in funding from Premier Venture Partners, LLC